WuXi AppTec

Global Platform
One Vision

Improving Health
Making a Difference

WuXi AppTec

Enabling Anyone,
Any Company

Entrusted by Over 3,000 Collaborative Partners

Our Vision

Every Drug Can Be Made and Every Disease Can Be Treated

Through Building the Open-access Platform with the Most Comprehensive Capabilities and Technologies in the Global Healthcare Industry

About Us

Enabling Innovation

Established in December 2000, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,600 collaborators from over 30 countries to improve the health of those in need – and to fulfill our dream that "every drug can be made and every disease can be treated."

Services and Solutions

An Open Enabling Platform

Enabling more than 3,500 Innovative Collaborators from more than 30 Countries

icon

Small Molecule Drug R&D and Manufacturing

icon

Cell Therapy
and Gene Therapy

icon

Drug R&D and Medical
Device Testing

icon

Clinical
Services

icon

Small Molecule Drug R&D and Manufacturing

Company Platform

Enabling Anyone, Any Company

To Become the Most Comprehensive Capability and Technology Platform in the Global Pharmaceutical and Healthcare Industry

Research Service Division

Providing a comprehensive end-to-end drug discovery solutions

Laboratory Testing Division

Providing integrated testing solution for drug development and medical device innovation

STA Pharmaceutical

Global leading platform for pharmaceutical development and manufacturing

Advanced Therapies Unit

Cell therapy and gene therapy R&D and production platform

WuXi Clinical

Providing global clinical development solutions, with dedicated resources in 60+ countries

MedKey

Clinical trial site operation for Phase I-IV pharmaceutical and medical device study.

LabNetwork

A global e-commerce platform linking R&D products, suppliers and buyers.

News

The Latest News About WuXi AppTec

WuXi AppTec Lists H Shares on the Hong Kong Stock Exchange

WuXi AppTec Expands Site in California for Pharmaceutical R&D Services

WuXi AppTec Receives 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan

WuXi AppTec Opens Its New Medical Device Testing Center in Suzhou

China Electronics Data and WuXi AppTec Form CW Data, a Joint Venture to Offer One-Stop Healthcare Big Data Solutions

WuXi AppTec Provides Easy Access to 80 Billion DNA-Encoded Small Molecules Libraries

Careers

Welcome to

Our Team

Become Part of Creating a Better Life

Investors

The Latest Financial Results, News and Resources